臨床試驗

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

NCT：NCT05637801 · COMPLETED

NCT IDNCT05637801

狀態COMPLETED

開始日期2022-12-13

完成時間2026-08-17

SponsorCognito Therapeutics, Inc. (INDUSTRY)

First posted2022-12-05

Last updated2026-09-09

簡要摘要

This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD. Up to approximately 670 subjects will be treated with either Active or Sham investigational device, Spectris™ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's Disease Mini-Mental State Exam (MMSE) Activities of Daily Living (ADCS-ADL) Rating Scale (iADMARS).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。